Chuang Hao-Yuan acquires 5,000 shares in Belite Bio, Inc.
Chuang Hao-Yuan has acquired 5,000 shares in Belite Bio, Inc. as part of a stock award, signaling executive commitment in the pharmaceutical sector.
Liuzza Nicholas Reyland JR Acquires 21,812 Restricted Stock Units
Nicholas Reyland JR acquires 21,812 restricted stock units from Red Cat Holdings, signaling confidence in the company's future.
Freedman Joseph David acquires restricted stock units in RCAT
Freedman Joseph David reported acquiring 23,683 restricted stock units in Red Cat Holdings, signaling strategic investment in the prepackaged software sector.
Funk Paul II Acquires 23,683 Restricted Stock Units from Red Cat
Funk Paul II reports acquisition of 23,683 restricted stock units from Red Cat Holdings, indicating strong commitment to the prepackaged software industry.
Moe Christopher R. acquires 23,683 restricted stock units
Christopher R. Moe reports acquisition of 23,683 restricted stock units in Red Cat Holdings, Inc., enhancing his stake in the company.
Davidson Matt Reports Major Stock Transactions After Merger
Davidson Matt discloses stock transactions post-Azora merger approval, highlighting significant changes in executive ownership and industry trends.
Julie Saiki Discloses Ownership Stakes in Adial Pharmaceuticals
Julie Saiki reports her ownership stakes in Adial Pharmaceuticals, highlighting her commitment as Chief Strategy Officer amid recent merger activities.
Acadia Pharmaceuticals CFO Reports Stock Transactions
Mark C. Schneyer, CFO of Acadia Pharmaceuticals, reported stock transactions, acquiring 6,815 shares and disposing of 3,321 shares for tax obligations.
Kim Denny Acquires 1,459 Shares of BCB Bancorp Stock
Kim Denny reports acquisition of 1,459 shares in BCB Bancorp, signaling commitment to the savings institution sector and potential impact on shareholder confidence.
Gryzlov Yury Sells Shares in Grid Dynamics Holdings, Inc.
Gryzlov Yury, COO of Grid Dynamics, sold 10,512 shares at $10.51 each as part of a trading plan, impacting the prepackaged software services sector.
GRID Dynamics CFO Anil Doradla sells 20,000 shares of stock
Anil Doradla, CFO of GRID Dynamics Holdings, sells 20,000 shares, indicating potential strategic financial adjustments within the company.
CEO Livschitz Leonard Sells 10,000 Shares of Grid Dynamics
Livschitz Leonard, CEO of Grid Dynamics, sold 10,000 shares of common stock as part of a trading plan, reducing his holdings amid market changes.
Sankar Shyam increases stake in Palantir Technologies
Sankar Shyam acquires additional shares of Palantir Technologies, boosting his holdings to over 857,000 shares. This reflects confidence in the company's future.
Palantir CFO Glazer Acquires 211,208 Shares of Stock
David A. Glazer, CFO of Palantir Technologies, acquires 211,208 shares, boosting his total holdings to 679,358 shares, signaling confidence in the company.
Palantir's Ryan D. Taylor Acquires 211,208 Shares of Stock
Taylor Ryan D. of Palantir Technologies acquired over 211,000 shares, signaling strong executive confidence in the company's future.
Sinensky Transfers 3 Million Shares to Family Trust in Amendment
Michael Sinensky reports a 3 million share transfer to a family trust in a Schedule 13D amendment, impacting Powerus Corp's governance.
SC US (TTGP) announces merger agreement with DoorDash
SC US (TTGP), LTD. reveals a merger agreement with DoorDash, impacting Maplebear Inc. and the broader business services sector.
Venrock Healthcare Capital Partners III Reports 5.1% Stake in Entera Bio
Venrock Healthcare Capital Partners III, L.P. discloses a 5.1% stake in Entera Bio Ltd., highlighting strategic interest in the biotechnology sector.
Rapport Therapeutics Sees Major Stock Acquisitions by Director
James Healy, director of Rapport Therapeutics, acquires significant shares, signaling confidence in the company's future amid industry trends.
Venrock Partners Acquire 11.9% Stake in Lycia Therapeutics
Venrock Healthcare Capital Partners and affiliates acquire 11.9% stake in Lycia Therapeutics, signaling investor confidence in the biological products sector.